Stock PEREGRINE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Peregrine Pharmaceuticals Nasdaq

Equities

US7136613046

Chart calendar Peregrine Pharmaceuticals

18f7738b8a71af29918552b375.OW_GNWLvmYBK_CG0f8-Co-omh0j5eCi6we81VnDbv20.dR2_fTSk2_Z6khfZEobw4J1zzzCLHR6OstkEG0ez-SlSDaNzW6ff-XyPQg~3c731861342a6010189cd7121bbc1562

Upcoming events on Peregrine Pharmaceuticals

05/09/2024 Q1 2025 Earnings Release (Projected)
03/12/2024 Q2 2025 Earnings Release (Projected)
17/03/2025 Q3 2025 Earnings Release (Projected)

Past events on Peregrine Pharmaceuticals

26/06/2024 Q4 2024 Earnings Release (Projected)
16/05/2024 08:45 pm BofA Securities Health Care Conference
15/05/2024 02:05 am RBC Capital Markets Global Healthcare Conference
30/04/2024 02:00 am Q3 2024 Earnings Call
25/04/2024 02:55 am Q3 2024 Earnings Release
08/12/2023 03:00 am Q2 2024 Earnings Call
08/12/2023 02:35 am Q2 2024 Earnings Release
23/10/2023 10:30 pm Annual General Meeting
03/10/2023 08:30 pm RBC Capital Markets CDMO Conference
08/09/2023 02:00 am Q1 2024 Earnings Call
08/09/2023 01:35 am Q1 2024 Earnings Release
22/06/2023 02:00 am Q4 2023 Earnings Call
22/06/2023 01:37 am Q4 2023 Earnings Release
17/05/2023 06:00 pm RBC Global Healthcare Conference
14/03/2023 02:00 am Q3 2023 Earnings Call
14/03/2023 01:35 am Q3 2023 Earnings Release
07/12/2022 03:00 am Interim 2023 Earnings Call
07/12/2022 02:35 am Interim 2023 Earnings Release
10/11/2022 02:20 am Credit Suisse Healthcare Conference
18/10/2022 10:30 pm Annual General Meeting

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		53,6
52,4
2.36%		59,7
55,9
6.86%		95,9
89,9
6.67%		120
117
1.93%		149
148
0.6%
139

EBITDA
Million USD		Released
Forecast
Spread 		-2,88
0,00
- 		-7,49
-7,76
3.38%		15,7
14,3
9.92%		30,4
27,2
12.06%		21,7
20,3
6.72%
1,81

EBIT
Million USD		Released
Forecast
Spread 		-5,62
-6,60
14.82%		-10,6
-13,5
21.34%		12,2
10,9
12.16%		15,4
18,2
-15.17%		3,60
3,16
13.88%
-17,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,34
-11,3
52.74%		-10,5
-10,7
1.95%		11,2
11,0
1.63%		12,7
12,1
4.65%		2,00
1,48
35.8%
-24,8

Net income
Million USD		Released
Forecast
Spread 		-8,90
-11,0
19.08%		-15,2
-14,5
-4.65%		3,32
5,61
-40.89%		128
12,1
955.26%		0,56
0,78
-28.25%
-20,1

EPS
USD		Released
Forecast
Spread 		-0,16
-0,18
8.57%		-0,27
-0,33
19%		0,06
0,09
-35.71%		1,84
0,19
885.7%		0,01
0,01
-20%
-0,32

Announcement Date27/06/1930/06/2029/06/2129/06/2221/06/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		31,5
25,3
24.51%		31,2
29,0
7.83%		36,7
33,4
9.71%		34,8
32,1
8.41%		38,0
36,3
4.68%		39,8
38,9
2.32%		37,7
36,1
4.55%		25,4
33,2
-23.55%		33,8
34,3
-1.39%
42,1


40,7


34,3


40,7


48,2

EBITDA
Million USD		Released
Forecast
Spread 		4,29
5,20
-17.38%		5,89
4,40
33.8%		6,19
5,92
4.56%		1,89
5,24
-64.03%		7,37
2,86
157.56%		6,27
4,91
27.66%		2,79
3,72
-24.88%		-5,97
1,77
-437.64%		-1,12
2,18
-151.22%
5,54


4,29


0,93


4,45


8,01

EBIT
Million USD		Released
Forecast
Spread 		3,27
3,00
8.98%		1,07
2,03
-47.45%		2,74
2,60
5.33%		-2,68
0,36
-853.93%		2,72
-2,24
221.26%		0,83
0,41
102.8%		-2,16
-1,61
-34.18%		-11,2
-4,40
-154.92%		-4,00
-3,38
-18.47%
-0,20


-1,40


-5,42


-1,53


2,10

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2,25
2,39
-5.78%		0,59
0,02
3568.75%		2,27
1,11
103.87%		-3,24
-0,15
-2132.01%		2,53
-2,83
189.42%		0,45
-0,07
776.23%		-2,68
-2,20
-21.86%		-11,9
-5,02
-136.89%		-7,06
-4,70
-50.15%
-3,17


-4,14


-8,16


-4,27


-0,64

Net income
Million USD		Released
Forecast
Spread 		2,25
2,39
-5.78%		116
0,02
722387.5%		1,56
1,01
55.06%		-1,16
-0,13
-762.69%		0,46
-2,30
120.02%		-0,31
-0,07
-333.68%		-2,09
-1,73
-21.18%		-9,51
-4,03
-135.98%		-6,01
-3,72
-61.66%
-2,46


-3,20


-6,32


-3,31


-0,51

EPS
USD		Released
Forecast
Spread 		0,04
0,04
0%		1,65
0,00
49649.55%		0,02
0,01
50.04%		-0,02
-0,01
-300%		0,01
-0,04
128.57%		0,00
0,00
- 		-0,03
-0,02
-28.59%		-0,15
-0,06
-140%		-0,09
-0,06
-56.52%
-0,04


-0,05


-0,10


-0,06


-0,01

Announcement Date08/03/2229/06/2206/09/2206/12/2213/03/2321/06/2307/09/2307/12/2306/03/24-----

Upcoming sector events for Peregrine Pharmaceuticals

11/07/2024 11:30 am BONESUPPORT HOLDING AB: Q2 2024 Earnings Release
16/07/2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release
23/07/2024 BIOGEN INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 11:30 am BIOGAIA AB: Q2 2024 Earnings Release
24/07/2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected)
25/07/2024 PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 10:30 am UCB: Q2 2024 Earnings Release
26/07/2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected)
30/07/2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Peregrine Pharmaceuticals

23/05/2024 03:13 pm CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release
14/05/2024 09:05 pm GRIFOLS, S.A.: Q1 2024 Earnings Release
14/05/2024 NATURECELL CO.,LTD.: Q1 2024 Earnings Release
10/05/2024 PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release
10/05/2024 MEDY-TOX INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release
09/05/2024 12:00 pm NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
09/05/2024 HUGEL, INC.: Q1 2024 Earnings Release
09/05/2024 01:46 am CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CDMO Stock
  4. Stock
  5. Calendar Peregrine Pharmaceuticals